Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Physiological and QoL Benefits of Qi-Gong in Post-acute Sequelae of Covid-19

  • Read more about Physiological and QoL Benefits of Qi-Gong in Post-acute Sequelae of Covid-19

Bedside Assessment of Immune Function in Patients With Covid-19

  • Read more about Bedside Assessment of Immune Function in Patients With Covid-19

Infant Malaria Vaccine Schedule Optimization

  • Read more about Infant Malaria Vaccine Schedule Optimization

Vima Therapeutics

By jpalfreyman on Mon, 03/17/2025 - 11:31
  • Read more about Vima Therapeutics

Medregen LLC

By jpalfreyman on Fri, 03/14/2025 - 13:36
  • Read more about Medregen LLC

Evaluating the Impact of a Functional and Cognitive Strategy in Patients with Long Covid-19

  • Read more about Evaluating the Impact of a Functional and Cognitive Strategy in Patients with Long Covid-19

Assessment of Vertigo and Dizziness in Individuals Following COVID-19

  • Read more about Assessment of Vertigo and Dizziness in Individuals Following COVID-19

Cetuximab Plus Platinum and Taxane-based Chemotherapy, Followed by Avelumab and Cetuximab, as First-line Treatment for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) Patients With a PD-L1 Combined Positive Score (CPS)≥1≤19.

  • Read more about Cetuximab Plus Platinum and Taxane-based Chemotherapy, Followed by Avelumab and Cetuximab, as First-line Treatment for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) Patients With a PD-L1 Combined Positive Score (CPS)≥1≤19.

Evaluation of MicroRNAs and Vitamin B12 Expression in Subjects with Neurologic Symptoms of Depression, Anxiety and Fatigue in Long COVID-19

  • Read more about Evaluation of MicroRNAs and Vitamin B12 Expression in Subjects with Neurologic Symptoms of Depression, Anxiety and Fatigue in Long COVID-19

A Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 (Influenza and COVID-19) Vaccine in Adults ≥18 to <65 Years of Age

  • Read more about A Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 (Influenza and COVID-19) Vaccine in Adults ≥18 to

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Current page 13
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA